Our SEKISUI Family
XenoTech was acquired by SEKISUI Medical Co. Ltd in August of 2008 and is now one of the companies comprising SEKISUI Medical Group. SEKISUI Medical Group is one of the four primary business divisions of SEKISUI Chemical Co., LTD. This alignment has allowed us to offer a comprehensive range of services to accelerate drug development, globally. SEKISUI XenoTech is also 1 of 11 subsidiaries that are a part of SEKISUI America Corporation, which represents SEKISUI Chemical in North America and supports each member company by providing reliable resources and assets. As the pioneering Japanese manufacturer in North America, SEKISUI America Corporation has become an unstoppable force of diverse companies striving to achieve satisfaction in Service, Speed, and Superiority while coexisting in harmony with our surroundings. Watch a short video on what these “3S” principles mean to the employees of SEKISUI America Corporation.
Focus on Growth & Advancement in the SEKISUI Medical Group
SEKISUI Medical Group is a global organization incorporating production (including pharmaceuticals, fine chemicals, and enzymes) with diagnostics and drug development. The group is focused on the advancement of new therapeutic research in human, animal and environmental science. To meet the challenges of increasing R&D costs, SEKISUI Medical Group is aggressively building onto its global contract research capabilities by aligning distinguished lineages of proven scientific expertise to accelerate R&D timelines, decrease costs and improve success rates via informed program decision-making. The group combines industry leaders and innovators including, but not limited to, SEKISUI Diagnostics (formerly the diagnostics arm of Genzyme), American Diagnostica Inc (ADI), Veredus Laboratories and, of course, SEKISUI XenoTech and SEKISUI Medical Co. (which integrates multiple former companies).
Through another SEKISUI Medical Group subsidiary, we can offer services in active pharmaceutical ingredient (API) manufacturing.
SEKISUI Medical’s multi-purpose current Good Manufacturing Practice (cGMP) facility is capable of both water-based and organic solvent-based manufacturing to meet any reaction and treatment needs with quality assurance testing and cutting-edge equipment. The Research & Development team can quickly and consistently support the manufacturing of grams up to kilograms of material, spanning pilot-scale up to industrial-scale manufacturing.
BioProduction by SEKISUI is a fermentation focused contract development and manufacturing organization (CDMO) with expertise in enzymes and downstream purification. Their microbial process development capabilities and production experience can assist you with smooth technical transfer and process scale-up.
- E. coli and yeast fermentation
- Plant tissue extraction
- Large scale bioprocessing
- Protein purification
- Bulk formulation
- Analytical testing
As part of SEKISUI Diagnostics, BioProduction has been a leader in the manufacturing of high-quality enzymes and specialty biochemicals to the global healthcare market for over 40 years. They have worked with many global partners to supply high-quality materials for a variety of applications, including enzymes and proteins for biotherapeutic manufacture, pharmaceutical production, diagnostic reagents, biosensors, and medical devices.